R Bax1, K Douville, D McCormick
1Biosyn, Inc, 1800 Byberry Road, Building 13, Huntingdon Valley, PA 19006, USA. rbax@biosyn-inc.com
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
A new microbicide gel, 1.0% C31G, shows promise for preventing sexually transmitted diseases (STDs) and HIV. This 3-day trial found it to be the safest and most acceptable formulation tested.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: